pharma sector : Latest News, Videos and Photos | Outlook Business
Home » Search
Search Result : "pharma sector"

The Nifty Pharma Index is down 27% over the past year amid pricing and regulatory pressure

With a mere 5% rise in sales in FY19, India’s auto industry is facing a challenging period

The pharma index has hugely underperformed the Sensex in CY17 owing to regulatory overhang and FDA issues 

Nilesh Shetty and Anand Shah on whether pharma stocks can make a comeback

Kotak Mahindra Bank MD & CEO Uday Kotak on the financial sector and the disruption in store

Over the past three years, the NSE Pharma Index has fallen 30% even as the benchmark Nifty rose 18%

Already grappling with falling sales in FY16, the auto sector has been further hit by measures in the Budget 

State-owned bank stocks have gained 30% in a month, post the recap announcement

The government’s decision to merge state-owned banks hardly provides a viable solution to key problems plaguing the sector

The Indian coal sector is facing growing risks on the back of oversupply and shift towards cleaner options

These companies have been ranked based on their stock's excess return over the Sensex for a five-year period

These companies have been ranked based on their stock's excess return over the Sensex for a five-year period

These companies have been ranked based on their stock's excess return over the Sensex for a five-year period

Renewed governmental interest and private sector investment has brought back the spotlight on solar-based mini grids

Amid slow growth and poor governance in financial services, Kotak Mahindra Bank continues to steer ahead with a clear growth strategy

Indian pharma majors are facing their toughest year yet in the US, with regulatory clampdown, hostile political environment and falling prices. Is reinvention the answer to their woes?

By integrating businesses seamlessly and scaling up prudently, DCM Shriram has done enviably well in an unpredictable sector

Despite the strong industry headwind, Torrent Pharma remains in the pink of health, thanks to its diversified geographical presence and specialty products

Solar Industries started off as an explosives trader in the eighties, but is now competing in the big league of defence supply

Generic Indian pharma players are changing their formula to focus on high-margin complex generics and specialty drugs

Despite headwinds in the auto sector, tyre stocks ride on replacement demand and falling raw-material cost

There are more fliers than ever before so why is the aviation sector stressed? The descent of Jet Airways provides a handy clue to what ails the sector

With a powerful client base and an all-in-one package, the contract R&D firm Syngene is galloping ahead and now even into manufacturing 

Edelweiss Securities' head of research sees huge potential in Dr Reddy's, and also an attractive valuation 

Stewart & Mackertich's head of research sees Engineers India benefitting from the revival of the hydrocarbon sector

Investors worry about poor corporate governance practices at Sun Pharma and price erosion in the US generics market